Lopinavir is a novel protease inhibitor (PI) developed from ritonavir. Coadministration with
low-dose ritonavir significantly improves the pharmacokinetic properties and hence the …

More than 40 years into the pandemic, HIV remains a global burden and as of now, there is
no cure in sight. Fortunately, highly active antiretroviral therapy (HAART) has been …

Background Evidence on the effectiveness of highly active antiretroviral therapy (HAART) for
HIV-infected individuals is limited. Most clinical trials examined surrogate endpoints over …

Background Results from observational studies suggest that micronutrient status is a
determinant of the progression of human immunodeficiency virus (HIV) disease. Methods …

Background The choice of optimal implant fixation in total hip replacement (THR)—fixation
with or without cement—has been the subject of much debate. Methods We performed a …

The chapter begins with a discussion of the empirical evidence for the extent of AIDS origin
conspiracy beliefs in the United States and South Africa (the only countries for which survey …

The purpose of this study was to describe mental health symptoms in a sample of 66 HIV-
positive youth (ages 16–25) and to evaluate social support, disclosure, and physical status …

Recent HIV treatment breakthroughs have lowered HIV mortality in the United States, but
have also coincided with increased HIV incidence. We argue that these trends are causally …

Background The effectiveness of the South African government's expanding antiretroviral
treatment program is unknown. Observational studies of treatment effectiveness are prone to …

In the last three decades, extensive research on human immunodeficiency virus (HIV) has
highlighted its capability to exploit a variety of strategies to enter and infect immune cells …